Raising a pre-seed round in healthtech.

At pre-seed, healthtech investors back people who understand how care is delivered and paid for. Here is what they look for and who usually writes the first checks.

Healthtech

Healthtech investors look past the demo to three questions: who pays, what evidence proves it works, and whether you can handle patient data safely. Long sales cycles shape every round.

What pre-seed investors expect in healthtech

There is no revenue to judge yet. Investors look at three things instead.

A team that knows care delivery

  • A clinician, operator or payer insider on the founding team
  • Someone who can explain how the workflow runs today
  • Advisors who can open doors to a first health system

A clear buyer and payer

  • Who uses it, who buys it and who pays may be three parties
  • Whether you sell to providers, payers, employers or patients
  • Why that buyer has budget for this problem now

A plan for patient data

  • Whether you will touch protected health information
  • How you will meet HIPAA from the first pilot
  • What you can test before handling real patient records

How the round comes together

Pre-seed healthtech money often comes from clinicians and operators who have lived the problem.

  • Angels from health care
  • Pre-seed funds
  • Accelerators

Angels

Often leads

Physicians and health executives write early checks and vouch for you with buyers.

Pre-seed & seed funds

Often leads

Pre-seed funds with a health focus back teams with deep domain insight.

Accelerators

Sometimes

Health-focused programs offer introductions to hospital and payer pilots.

Angel groups

Sometimes

Groups with many physician members often review healthtech deals.

Grants & non-dilutive

Now and then

Public research grants can fund digital health studies before revenue.

SAFE or priced round?

Almost every pre-seed round is a SAFE or convertible note. Healthtech sales cycles are long, so the cap you set now may convert later than you expect. Model it before the first call.

The slides investors read first

Team

Who has worked inside care delivery or a payer?

Problem

The workflow pain and who feels it daily.

Who pays

User, buyer and payer, named separately.

Data and privacy

How you will handle patient data safely.

The ask

Amount, instrument and the pilot it funds.

Questions founders ask

Do I need a clinician on the founding team?

Not always, but investors want clinical insight close to the product. A clinical co-founder or committed clinical advisors make the story far more credible.

Should I raise before I am HIPAA compliant?

Yes, many founders do. Investors want a clear plan for compliance before you handle real patient data, not a finished program on day one.

Sources

Sources: HHS guidance on HIPAA; FDA guidance on digital health software; CMS reimbursement resources; investors' published criteria. Editorial content, reviewed quarterly. Not financial, legal or medical advice.

Other stages

Seed

Series A

Series B and later

Growth

Related sectors

Medtech

Biotech

AI / ML

SaaS

Cybersecurity

Who funds this round

Angels

Pre-seed & seed funds

Accelerators

Angel groups

Grants & non-dilutive

Learn the terms

SAFE or priced round?

Caps and discounts

Convertible notes

Warm introductions

Run the numbers

Round-size benchmark

SAFE dilution calculator

Runway & raise timing

Raise in your city

New York

Los Angeles

Boston

Chicago

Austin

Denver

Inside Unicorn Factory

Free account

Investor matching is coming to your free account. Create it now and we will match your round the day it opens. Until then, get an honest read on your deck.

Score my deck free

Get matched when it opens

Score my deck free